The external defibrillators market is expected to garner $7,512 million in the next two years, registering a compound annual growth rate (CAGR) of 7.8% during the forecast period 2017 – 2023.
The global market was valued at $4,345 million in 2016 and is expected to hit the $7,512 million mark by 2023, according to the new report published by Allied Market Research.
External defibrillators are devices used to deliver therapeutic shock to a patients heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The major factors that boost the market growth include technological advancements such as advent of automated external defibrillators (AEDs) for public access places, rise in incidence of sudden cardiac arrest, and growth in awareness toward public access defibrillators worldwide.
Automated external defibrillators (AEDs) segment accounted for more than five-sevenths share of the global market in 2016.
Wearable cardioverter defibrillator (WCDs) is poised to grow at the fastest rate during the forecast period owing to the non-invasive nature and increased demand of home healthcare for the treatment of sudden cardiac arrest. Wearable external defibrillator segment is expected to grow at a remarkable CAGR of 11.3% from 2017-2023.
This report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.